The impact of age on survival in CLL patients receiving ibrutinib as initial therapy

Chaitra Ujjani, Anthony Mato, Brian Hill, John Allan, Erick Lansigan, Alan Skarbnik, Ryan Jacobs, Meghan Thompson, Jakub Svoboda, Hande H Tuncer, John Pagel, Danielle Brander, Bruce D Cheson, Paul Barr, Clive S Zent, Joanna Rhodes, Lindsey Roeker, Jeffrey Pu, Sasanka Handunnetti, Chadi Nabhan Show all